Article
Open-label phase 1b pilot study to assess the antiviral efficacy of simvastatin combined with sertraline in chronic hepatitis C patients.
Antiviral therapy - 1 Jan 2011
Patel Keyur, Lim Seng G, Cheng Chow W, Lawitz Eric, Tillmann Hans L, Chopra Narinder, Altmeyer Ralf, Randle John C R, McHutchison John G
Abstract excerpt
BACKGROUND: 3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors inhibit HCV replication in vitro. The combination of sertraline and simvastatin has synergistic antiviral activity in vitro, but there are no prior in vivo studies. Our aims were to prospectively assess the antiviral efficacy and safety of this drug combination in chronic hepatitis C (CHC) patients. METHODS: A total of 15 CHC adults...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
